Mrv1652304251823492D 16 15 0 0 0 0 999 V2000 10018.531810018.7422 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 10018.531810019.7487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10019.246410020.1611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10019.959910019.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10020.673410020.1611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10021.391110019.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10019.246410020.9840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10019.254710018.3432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10019.254710017.5185 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 10018.153110016.8578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10019.965910017.1053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10019.110310016.7063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10017.817710018.3290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10017.103510018.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10016.389410018.3290 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 10017.103510019.5673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 1 0 0 0 1 8 1 0 0 0 0 1 13 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 3 7 2 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 9 12 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 14 16 2 0 0 0 0 M CHG 2 9 1 15 -1 M END > BMDB0002013 > bmdb > CCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C > InChI=1S/C11H21NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h9H,5-8H2,1-4H3/t9-/m1/s1 > QWYFHHGCZUCMBN-SECBINFHSA-N > C11H21NO4 > 231.292 > 231.14705816 > 3 > 37 > 24.796522551548037 > 1 > 0 > 0 > 0 > (3R)-3-(butanoyloxy)-4-(trimethylazaniumyl)butanoate > -2.10 > -3.3012761258050785 > -3.74 > 0 > 0 > 0 > 4.26892391250365 > -7.057078620656008 > 66.43 > 81.8647 > 8 > 1 > 5.23e-02 g/l > O-butanoylcarnitine > 0 > BMDB0002013 > Butyrylcarnitine > (3-carboxy-2-hydroxypropyl)trimethyl-L-butyrate; (R)-3-carboxy-N,N,N-trimethyl-2-(1-oxobutoxy)-1-Propanaminium; Butyryl-L-carnitine; ester with (3-carboxy-2-hydroxypropyl)trimethylammonium L-Butyric acid; ester with L-(3-carboxy-2-hydroxypropyl)trimethylammonium Butyric acid; L-Carnitine butyryl ester; n-Butyryl-L(-)-carnitine; O-Butanoylcarnitine $$$$